Drug recall D-0837-2020
Product
Methylphenidate hydrochloride Extended-Release ablets USP (CII), 27 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-734-01
Reason for recall
CGMP deviations: Product bottle may be absent of desiccant.
Lots and codes
Lot # 1332799A, Exp 11/2020
Recall details
- Recalling firm
- Teva Pharmaceuticals USA, Parsippany, NJ
- Quantity
- 17,436 bottles
- Distribution
- USA Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 27, 2020
- Terminated
- November 3, 2020
Related products
- Methylphenidate Hydrochloride – drug information
- NDC 62037-734 Methylphenidate Hydrochloride · Methylphenidate Hydrochloride 27 mg/1 · Actavis Pharma, Inc.
- NDC 62037-725 Methylphenidate Hydrochloride · Methylphenidate Hydrochloride 18 mg/1 · Actavis Pharma, Inc.
- NDC 62037-726 Methylphenidate Hydrochloride · Methylphenidate Hydrochloride 36 mg/1 · Actavis Pharma, Inc.
- NDC 62037-727 Methylphenidate Hydrochloride · Methylphenidate Hydrochloride 54 mg/1 · Actavis Pharma, Inc.